3Kopp R,Classen S,Wolf H,et al.Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormoneor chemotherapy in patients with metastatic breast cancer[J].Anticancer Research,2001,21(4):2 995-3 000.
4Andrea K,Karin W,Andreas O,et al.Vascular endothelial growth factor in the seraand effusions of patients with malignant and nonmalignant disease[J].Cancer,1999,85(1):178-187.
5Gulmann C,Grace A,Leader M,et al.CD44v6:a potential marker of malignant trans-formation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays[J].European Journal of Gastroenterology and Hepatology,2003,15(9):981-986.
6Jothy S.CD44 and its partners in metastasis[J].Clinical and Experimental Metastasis,2003,20(3):195-201.
7Weg Remers S,Hildebrandt U,Feifel G,et al.Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6[J].American Journal of Gastroenterology,1998,93(5):790-794.
8Kanenori E,Tadashi T.Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma:relationships with tumor grade,clinicopathologic parameters,p53 expression,and patient survival[J].Journal of Hepatology,2000,32(1):78-84.
9Marti HH.Vascular endothelial growth factor[J].Advances in Experimental Medicine and Biology,2002,513(1):375-394.
10Neufeld G,Cohen T,Gengrinovitch S,et al.Vascular endothelial growth factor and its receptors[J].FASEB J,1999,13(1):9-22.
